Glaxo (GSK) Upgraded to Buy: What Does It Mean for the Stock?
https://www.zacks.com/stock/news/2193139/glaxo-gsk-upgraded-to-buy-what-does-it-mean-for-the-stock?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_12_zacks_rank_upgrade-2193139
Dec 04, 2023 - Glaxo (GSK) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
0
GSK vs. VRTX: Which Stock Should Value Investors Buy Now?
https://www.zacks.com/stock/news/2193083/gsk-vs-vrtx-which-stock-should-value-investors-buy-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_3-2193083
Dec 04, 2023 - GSK vs. VRTX: Which Stock Is the Better Value Option?
0
Is GSK PLC Sponsored ADR (GSK) Stock Outpacing Its Medical Peers This Year?
https://www.zacks.com/stock/news/2192952/is-gsk-plc-sponsored-adr-gsk-stock-outpacing-its-medical-peers-this-year?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_1-2192952
Dec 04, 2023 - Here is how GSK (GSK) and Acadia Pharmaceuticals (ACAD) have performed compared to their sector so far this year.
0